Français
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
phenylalanine/neoplasms
Le lien est enregistré dans le presse-papiers
Page 1 de 50 résultats
Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
SEQUENCE LISTING
A CRF copy of the Sequence Listing, titled 011808-0014-999_SeqListing.txt, which was saved on Apr. 22, 2008 and is 53 kbs in size is submitted herewith and is incorporated herein by reference in its entirety.
FIELD OF THE INVENTION
This invention relates to prokaryotic phenylalanine
Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
SEQUENCE LISTING
A CRF copy of the Sequence Listing, titled 11808-069-999_SeqListing.txt, which was saved on Apr. 8, 2009 and is 53,833 bytes in size is submitted herewith and is incorporated herein by reference in its entirety
FIELD OF THE INVENTION
This invention relates to prokaryotic
Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
SEQUENCE LISTING
A CRF copy of the Sequence Listing, titled 011808-0013-999_SeqListing.txt, which was saved on Apr. 22, 2008 and is 53 kbs in size is submitted herewith and is incorporated herein by reference in its entirety.
FIELD OF THE INVENTION
This invention relates to prokaryotic phenylalanine
Phenylalanine-glycine compounds having anti-tumor activity, process for preparation thereof, and pharmaceutical composition containing said compounds
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to a novel conjugate of a phenylalanine derivative with an antitumor substance, a process for preparation thereof, and a pharmaceutical composition, in particular, an antitumor agent, containing it. More
Phenylalanine derivatives
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
BACKGROUND OF THE INVENTION
The present invention relates to new phenylalanine derivatives and the use of the phenylalanine derivatives as medicines. It was reported that .alpha.4 integrins participate in diseases in which .alpha.4 integrin-depending adhesion process participates in the pathology,
Phenylalanine derivatives
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
BACKGROUND OF THE INVENTION
The present invention relates to new phenylalanine derivatives and the use of the phenylalanine derivatives as medicines. It was reported that .alpha. 4 integrins participate in diseases in which .alpha. 4 integrin-depending adhesion process participates in the pathology,
Phenylalanine derivatives
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
BACKGROUND OF THE INVENTION
The present invention relates to new phenylalanine derivatives and the use of the phenylalanine derivatives as medicines. The present invention also relates to the compounds usable as therapeutic agents or preventive agents for inflammatory diseases in which .alpha.4
Phenylalanine derivatives
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
BACKGROUND OF THE INVENTION
The present invention relates to new phenylalanine derivatives and the use of the phenylalanine derivatives as medicines. The present invention also relates to the compounds usable as therapeutic agents or preventive agents for inflammatory diseases in which .alpha.4
Method of using beta-hydroxy-beta-methylbutyrate for reducing tumor growth rate
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
The present invention relates to methods for the prevention and treatment of chronic inflammatory diseases, cancer, and involuntary weight loss. In the practice of the present invention patients are enterally administered HMB alone or alternatively in combination with eicosapentaenoic (20:5
Phenylalanine derivatives
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
TECHNICAL FIELD OF THE INVENTION
The present invention relates to novel phenylalanine derivatives, compositions, and a method of using these derivatives in inhibiting SH2 domain binding with a phosphoprotein. The present invention further provides precursors suitable for preparing the phenylalanine
Stable dosage form of phenylalanine derivatives
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
CROSS REFERENCE TO RELATED APPLICATION
This application is a 35 USC .sctn.371 National Phase Entry Application from PCT/EP2005/010143, filed Sep. 20, 2005, and designating the United States.
The invention relates to improved and stable pharmaceutical formulations of phenylalanine derivatives and to
Therapy of malignant neoplasias
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a 35 U.S.C. .sctn.371 filing of PCT/EP2006/011367, filed Nov. 27, 2006. PCT/EP2006/011367 claims the benefit of European Patent Application No. 05025776.5, filed Nov. 25, 2005. The disclosures of the aforementioned applications are
Methods and pharmaceutical compositions for the treatment of cancer
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
FIELD OF THE INVENTION
The present invention relates to methods and pharmaceutical compositions for the treatment of cancer.
BACKGROUND OF THE INVENTION
Cancer treatments which target several pathways within cancer cells have been developed recently. However, some type of cancers exhibit different
Methods for killing PSMA-expressing, taxane-resistant cancer cells
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
BACKGROUND OF THE INVENTION
Prostate cancer is the most common malignancy and the second leading cause of cancer death in men in the United States (Jemal A, et al., CA Cancer J Clin 2005; 55:10-30). Localized prostate cancer typically is treated with surgery or radiation, and recurrent disease can
Therapy of malignant neoplasias
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
The present invention provides a method for the treatment of malignant neoplasias comprising the step of administering an L-phenylalanine conjugated to a beta- or alpha-emitting isotope to a subject in the need thereof. Moreover, the invention provides a method for the monitoring of the progress of
La base de données d'herbes médicinales la plus complète soutenue par la science
- Fonctionne en 55 langues
- Cures à base de plantes soutenues par la science
- Reconnaissance des herbes par image
- Carte GPS interactive - étiquetez les herbes sur place (à venir)
- Lisez les publications scientifiques liées à votre recherche
- Rechercher les herbes médicinales par leurs effets
- Organisez vos intérêts et restez à jour avec les nouvelles recherches, essais cliniques et brevets
Tapez un symptôme ou une maladie et lisez des informations sur les herbes qui pourraient aider, tapez une herbe et voyez les maladies et symptômes contre lesquels elle est utilisée.
* Toutes les informations sont basées sur des recherches scientifiques publiées
